Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LPCN 1148

Next Previous
Search
Drug Profile

LPCN 1148

Alternative Names: LPCN-1148

Latest Information Update: 28 Aug 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Lipocine
  • Class Anabolic steroids; Androstenols; Hepatoprotectants; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Androgen receptor agonists; Testosterone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Liver cirrhosis

Highest Development Phases

  • Phase II Liver cirrhosis
  • No development reported Non-alcoholic fatty liver disease

Most Recent Events

  • 28 Aug 2024 No recent reports of development identified for phase-I development in Non-alcoholic-fatty-liver-disease in USA (PO)
  • 05 Jun 2024 Efficacy and adverse events data from the phase II trial in Liver cirrhosis was presented at European Association for the Study of the Liver Congress 2024 (EASL-2024)
  • 28 Mar 2024 Efficacy and safety data from a phase II trial in Liver cirrhosis released by Lipocine

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top